The risk and added values of the atherosclerotic cardiovascular risk enhancers on prediction of cardiovascular events: Tehran lipid and glucose study

BACKGROUND: In 2013 American College of Cardiology and the American Heart Association released a guideline on the management of atherosclerotic cardiovascular disease (ASCVD) including a composite of death from CVD, non-fatal myocardial infarction, or non-fatal stroke (hard CVD). This guideline reco...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Transl Med
Autori principali: Hadaegh, Farzad, Asgari, Samaneh, Moosaie, Fatemeh, Orangi, Meysam, Sarvghadi, Farzaneh, Khalili, Davood, Azizi, Fereidoun
Natura: Artigo
Lingua:Inglês
Pubblicazione: BioMed Central 2021
Soggetti:
Research
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7789723/
https://ncbi.nlm.nih.gov/pubmed/33407576
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12967-020-02686-1
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi